Search research articles
Contact Us
Filters
Showing results (221-230 of 287) with videos related to
Page
of 29
Sort By:
Cancer Genetics and Cytogenetics
|
October 15, 1989
Translocation t(6;9) occurring in acute myelofibrosis, myelodysplastic syndrome, and acute nonlymphocytic leukemia suggests multipotent stem cell involvement
A Cuneo, S Kerim, E Vandenberghe, et al.
Blood
|
October 1, 1989
Multipotent stem cell involvement in megakaryoblastic leukemia: cytologic and cytogenetic evidence in 15 patients
A Cuneo, C Mecucci, S Kerim, et al.
British Journal of Haematology
|
October 1, 1991
Follow-up of residual disease (MRD) in B lineage acute leukaemias using a simplified PCR strategy: evolution of MRD rather than its detection is correlated with clinical outcome
Y Nizet, P Martiat, J L Vaerman, et al.
Cancer Genetics and Cytogenetics
|
July 15, 1996
ider(9)(q10)t(9;22)(q34;q11) is a recurrent chromosomal abnormality in acute lymphoblastic leukemia and lymphatic blastic phase of chronic myelogenous leukemia
J Dierlamm, L Michaux, N Kröger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 24, 1999
Low-grade stage III-IV follicular lymphoma: multivariate analysis of prognostic factors in 484 patients--a study of the groupe d'Etude des lymphomes de l'Adulte
D Decaudin, E Lepage, N Brousse, et al.
Cancer Genetics and Cytogenetics
|
July 21, 2001
Chromosomal gains and losses are uncommon in hairy cell leukemia: a study based on comparative genomic hybridization and interphase fluorescence in situ hybridization
J Dierlamm, M Stefanova, I Wlodarska, et al.
Journal of Clinical Immunology
|
January 1, 1993
Correlation between soluble serum CD16 (sCD16) levels and disease stage in patients with multiple myeloma
C Mathiot, J L Teillaud, M Elmalek, et al.
Leukemia Research
|
December 29, 1999
Mature plasma cells as indicator of better prognosis in multiple myeloma. New methodology for the assessment of plasma cell morphology
J E Goasguen, M Zandecki, C Mathiot, et al.
Genes, Chromosomes & Cancer
|
September 1, 1995
Fluorescence in situ hybridization identifies new chromosomal changes involving 3q27 in non-Hodgkin's lymphomas with BCL6/LAZ3 rearrangement
I Wlodarska, C Mecucci, M Stul, et al.
American Journal of Hematology
|
February 1, 1995
Prognostic factors in low tumour mass asymptomatic multiple myeloma: a report on 91 patients. The Groupe d'Etudes et de Recherche sur le Myélome (GERM)
T Facon, J F Menard, J L Michaux, et al.
Page
of 29
Search research articles
Search
Showing results (221-230 of 287) with videos related to
Sort By:
Page
of 29
Cancer Genetics and Cytogenetics
|
October 15, 1989
Translocation t(6;9) occurring in acute myelofibrosis, myelodysplastic syndrome, and acute nonlymphocytic leukemia suggests multipotent stem cell involvement
A Cuneo, S Kerim, E Vandenberghe, et al.
Blood
|
October 1, 1989
Multipotent stem cell involvement in megakaryoblastic leukemia: cytologic and cytogenetic evidence in 15 patients
A Cuneo, C Mecucci, S Kerim, et al.
British Journal of Haematology
|
October 1, 1991
Follow-up of residual disease (MRD) in B lineage acute leukaemias using a simplified PCR strategy: evolution of MRD rather than its detection is correlated with clinical outcome
Y Nizet, P Martiat, J L Vaerman, et al.
Cancer Genetics and Cytogenetics
|
July 15, 1996
ider(9)(q10)t(9;22)(q34;q11) is a recurrent chromosomal abnormality in acute lymphoblastic leukemia and lymphatic blastic phase of chronic myelogenous leukemia
J Dierlamm, L Michaux, N Kröger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 24, 1999
Low-grade stage III-IV follicular lymphoma: multivariate analysis of prognostic factors in 484 patients--a study of the groupe d'Etude des lymphomes de l'Adulte
D Decaudin, E Lepage, N Brousse, et al.
Cancer Genetics and Cytogenetics
|
July 21, 2001
Chromosomal gains and losses are uncommon in hairy cell leukemia: a study based on comparative genomic hybridization and interphase fluorescence in situ hybridization
J Dierlamm, M Stefanova, I Wlodarska, et al.
Journal of Clinical Immunology
|
January 1, 1993
Correlation between soluble serum CD16 (sCD16) levels and disease stage in patients with multiple myeloma
C Mathiot, J L Teillaud, M Elmalek, et al.
Leukemia Research
|
December 29, 1999
Mature plasma cells as indicator of better prognosis in multiple myeloma. New methodology for the assessment of plasma cell morphology
J E Goasguen, M Zandecki, C Mathiot, et al.
Genes, Chromosomes & Cancer
|
September 1, 1995
Fluorescence in situ hybridization identifies new chromosomal changes involving 3q27 in non-Hodgkin's lymphomas with BCL6/LAZ3 rearrangement
I Wlodarska, C Mecucci, M Stul, et al.
American Journal of Hematology
|
February 1, 1995
Prognostic factors in low tumour mass asymptomatic multiple myeloma: a report on 91 patients. The Groupe d'Etudes et de Recherche sur le Myélome (GERM)
T Facon, J F Menard, J L Michaux, et al.
Page
of 29